X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Merck Ltd Fact Sheet, Merck Ltd Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Merck Ltd Fact Sheet   (EMER)

Here is the latest financial fact sheet of Merck Ltd. For more details, see the Merck Ltd quarterly results and Merck Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

MERCK LTD Price History

Price Rs 1,085.0
Mkt Cap Rs m 18,011
Vol '000 85.1
P/E X 24.9
P/CF X 17.4
EPS (TTM) Rs 43.5
% ch % -1.4
No. of shares m 16.60
% ch week % 0.1
% ch 1-mth % 4.0
% ch 12-mth % 54.8
52 week H/L Rs 1,198.9/681.0
(As on Jun 23, 2017 03:37:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

MERCK LTD Financials

No. of Mths
Year Ending
12
Dec-12
12
Dec-13
12
Dec-14
12
Dec-15
12
Dec-16
5-Yr Chart
Click to enlarge
MERCK LTD EQUITY SHARE DATA
High Rs7146899191,0041,060 
Low Rs555523536716623 
Sales per share (Unadj.) Rs414.0480.6522.6566.0632.4 
Earnings per share (Unadj.) Rs47.233.726.032.345.7 
Diluted earnings per shareRs47.233.726.032.345.7 
Cash flow per share (Unadj.) Rs52.639.733.746.462.3 
Dividends per share (Unadj.) Rs2.508.506.007.5011.00 
Adj. dividends per shareRs2.508.506.007.5011.00 
Dividend yield (eoy) %0.41.40.80.91.3 
Book value per share (Unadj.) Rs291.4315.1333.9356.4388.8 
Adj. book value per shareRs291.4315.1333.9356.4388.8 
Shares outstanding (eoy) m16.6016.6016.6016.6016.60 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.51.31.41.51.3 
Avg P/E ratio x13.418.027.926.718.4 
P/CF ratio (eoy) x12.115.221.618.513.5 
Price / Book Value ratio x2.21.92.22.42.2 
Dividend payout %5.325.323.023.224.1 
Avg Mkt Cap Rs m10,53310,05612,07514,27613,969 
No. of employees `0001.31.51.51.61.6 
Total wages/salary Rs m8531,0101,1361,2341,487 
Avg. sales/employee Rs Th5,382.05,332.85,726.06,045.76,631.9 
Avg. wages/employee Rs Th668.0674.9749.6794.0939.2 
Avg. net profit/employee Rs Th613.9373.5285.3344.7479.4 
MERCK LTD INCOME DATA
Net Sales Rs m6,8737,9788,6759,39510,498 
Other income Rs m202215203233242 
Total revenues Rs m7,0758,1928,8789,62810,741 
Gross profit Rs m1,0557695898341,135 
Depreciation Rs m89101127234276 
Interest Rs m00000 
Profit before tax Rs m1,1688836668331,102 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m384324233298343 
Profit after tax Rs m784559432536759 
Gross profit margin %15.39.66.88.910.8 
Effective tax rate %32.936.735.135.731.1 
Net profit margin %11.47.05.05.77.2 
MERCK LTD BALANCE SHEET DATA
Current assets Rs m4,5854,7774,9865,7246,410 
Current liabilities Rs m9711,1201,3521,6598,828 
Net working cap to sales %52.645.841.943.3-23.0 
Current ratio x4.74.33.73.50.7 
Inventory Days Days7069756558 
Debtors Days Days3438444938 
Net fixed assets Rs m7699411,3731,3871,406 
Share capital Rs m166166166166166 
"Free" reserves Rs m4,6685,0625,3745,7476,286 
Net worth Rs m4,8375,2305,5435,9166,455 
Long term debt Rs m00000 
Total assets Rs m5,9436,4837,0827,8408,828 
Interest coverage xNMNMNMNMNM 
Debt to equity ratio x00000 
Sales to assets ratio x1.21.21.21.21.2 
Return on assets %13.28.66.16.88.6 
Return on equity %16.210.77.89.111.8 
Return on capital %24.116.912.014.117.1 
Exports to sales %10.68.97.88.58.3 
Imports to sales %22.423.722.821.621.0 
Exports (fob) Rs m730708677802869 
Imports (cif) Rs m1,5401,8881,9812,0262,209 
Fx inflow Rs m802746824874959 
Fx outflow Rs m1,8962,2812,3112,3562,612 
Net fx Rs m-1,094-1,535-1,487-1,483-1,653 
MERCK LTD CASH FLOW
From Operations Rs m 543 5 50 835 1,070 
From Investments Rs m -818 70 106 -678 -750 
From Financial Activity Rs m 0 -48 -166 -119 -150 
Net Cashflow Rs m -276 27 -11 37 171 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 51.8%
Indian inst/Mut Fund 18.2%
FIIs 1.0%
ADR/GDR 0.0%
Free float 29.1%
Shareholders 28,591
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Shiv Sagar Estate 'A', Dr. Annie Besant Road, Worli, Mumbai - 400 018
E-MAIL vikas.r.gupta@merckgroup.com WEB www.merck.co.in
TELEPHONE (022) 6660 9111 FAX (022) 2495 0307
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
AUDITOR B. S. R & Co.
CHM: S. N. Talwar COMP SEC: Vikas R. Gupta YEAR OF INC: 1967 BSE CODE: 500126 FV (Rs): 10 DIV YIELD (%): 1.0

More Pharmaceuticals Company Fact Sheets:   ALEMBIC LTD  VENUS REMEDIES  PLETHICO PHARMA  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare MERCK LTD With:   ALEMBIC LTD  VENUS REMEDIES  PLETHICO PHARMA  ASTRAZENECA PHARMA  UNICHEM LAB  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak End to the Week; Auto & PSU Stocks Fall(Closing)

Profit booking continued in the afternoon session in the Indian share markets amid weak European cues. At the closing bell, the BSE Sensex stood lower by 153 points.

Views on news

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

Digital Transactions were Growing Faster Before Demonetisation(Vivek Kaul's Diary)

Jun 12, 2017

Which brings us back to the basic question, why was demonetisation carried out?

A Pharma IPO in a Market That Loves IPOs but Hates Pharma(The 5 Minute Wrapup)

Jun 15, 2017

Tomorrow comes the IPO of Eris Lifesciences. How will a pharma IPO do in this market?

Get Ready for Commodity Options!(Daily Profit Hunter)

Jun 16, 2017

Commodity options trading is one step closer to reality. Learn how to take advantage of this tremendous opportunity.

Should You Trade In Mutual Funds As You Do In Stocks?(Outside View)

Jun 10, 2017

Trading is not synonymous with mutual funds, PersonalFN explains.

Which Way Will Inflation Go?(Chart Of The Day)

Jun 10, 2017

RBI and government at loggerheads over interest rates.

More

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MERCK LTD

MERCK LTD - ADCOCK INGRAM COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS